Add like
Add dislike
Add to saved papers

Association of serum cytokines with coronary chronic total occlusion (CTO) and their role in predicting procedural outcomes.

BACKGROUND: Cytokines are strongly associated with coronary artery disease (CAD); however, few studies have explored the relevance of cytokines in coronary chronic total occlusion (CTO). This study aimed to clarify the association of cytokines with CTO and its procedural outcomes.

METHODS: A total of 526 patients with suspected CAD but not acute myocardial infarction were enrolled and divided into CTO (n = 122) and non-CTO (n = 404) groups based on coronary angiography. Furthermore, serum levels of 12 cytokines [Interleukin-1β (IL-1β), IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, tumor necrosis factor-α (TNF-α), interferon-α (IFN-α), and IFN-γ] were measured for each patient.

RESULTS: Patients with CTO had higher rates of male (P=0.001), smoking (P=0.014), and diabetes (P=0.008); higher levels of IL-6 (P<0.001), total triglycerides (P=0.020), serum creatine (P=0.001), and high-sensitivity troponin I (P=0.001); and lower IL-4 (P<0.001), total cholesterol (P=0.027), and high-density lipoprotein cholesterol (HDL-C) (P<0.001) levels compared to those without CTO. IL-4 (OR=0.216, 95%CI:0.135-0.345, P<0.001), IL-6 (OR=1.248, 95%CI:1.165-1.337, P<0.001), and HDL-C (OR=0.047, 95%CI:0.010-0.221, P<0.001) were identified as independent predictors of CTO. And good predictive performance (AUC=0.876) for CTO, with a sensitivity of 81.96% and specificity of 81.19%, could be achieved by combining these three predictors. Furthermore, patients with procedural success had younger age (P=0.004) and lower serum IL-6 levels (P=0.039) compared to those with procedural failure, and IL-6 levels (OR=0.962, 95%CI: 0.931-0.995, P=0.023) were associated with procedural success.

CONCLUSION: IL-4, IL-6, and HDL-C levels were strongly associated with CTO, and IL-6 also linked to procedural outcomes of CTO.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app